Valuation: Progyny, Inc.

Capitalization 1.41B 1.2B 1.1B 1.04B 1.93B 132B 1.97B 12.93B 5.09B 63.36B 5.29B 5.19B 225B P/E ratio 2026 *
15.4x
P/E ratio 2027 * 13.2x
Enterprise value 1.24B 1.06B 970M 920M 1.7B 116B 1.73B 11.39B 4.48B 55.81B 4.66B 4.57B 198B EV / Sales 2026 *
0.9x
EV / Sales 2027 * 0.7x
Free-Float
76.13%
Yield 2026 *
-
Yield 2027 * -
1 day-3.33%
1 week+4.95%
Current month+6.12%
1 month-0.61%
3 months-29.19%
6 months-7.16%
Current year-29.83%
1 week 17.33
Extreme 17.33
18.98
1 month 16.1
Extreme 16.1
18.98
Current year 16.1
Extreme 16.1
28.75
1 year 16.1
Extreme 16.1
28.75
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2022
Director of Finance/CFO 60 15/09/2020
Chief Operating Officer 56 17/04/2025
Director TitleAgeSince
Chairman 66 01/01/2022
Director/Board Member 77 16/12/2016
Director/Board Member 58 01/01/2022
Change 5d. change 1-year change 3-years change Capi.($)
-3.33%+4.95%-15.68%-47.98% 1.41B
+6.96%+10.13%-18.65%-28.48% 314B
-1.15%+1.50%-14.80%+9.75% 72.95B
+2.74%+4.71%-19.32%-27.21% 72.07B
+3.34%+10.78%-11.61%-55.75% 26.1B
+2.17%+5.05%-32.53%-40.69% 19.25B
+0.59%+2.37%-50.01%-45.20% 7.87B
0.00%+1.32%+23.20%+305.26% 4.4B
+7.17%+17.16%-28.01%+205.78% 1.25B
+0.24%+5.62%-18.50% - 295M
Average +1.87%+4.51%-18.59%+30.61% 51.99B
Weighted average by Cap. +4.69%+3.38%-18.50%-21.67%

Financials

2026 *2027 *
Net sales 1.38B 1.17B 1.07B 1.02B 1.88B 129B 1.92B 12.6B 4.96B 61.73B 5.16B 5.05B 219B 1.51B 1.28B 1.18B 1.12B 2.06B 141B 2.1B 13.82B 5.44B 67.69B 5.66B 5.54B 240B
Net income 102M 86.76M 79.58M 75.5M 139M 9.54B 142M 934M 368M 4.58B 383M 375M 16.26B 120M 102M 93.27M 88.49M 163M 11.18B 167M 1.1B 431M 5.37B 448M 439M 19.05B
Net Debt -168M -143M -131M -124M -229M -15.73B -235M -1.54B -606M -7.55B -631M -618M -26.8B -359M -305M -280M -266M -490M -33.58B -501M -3.29B -1.29B -16.11B -1.35B -1.32B -57.23B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
21/04/26 18.02 $ -3.33% 1,301,829
20/04/26 18.64 $ +2.87% 1,075,801
17/04/26 18.12 $ +1.06% 1,086,108
16/04/26 17.93 $ +3.11% 1,301,826
15/04/26 17.39 $ +1.28% 1,553,057
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
18.02USD
Average target price
27.45USD
Spread / Average Target
+52.36%

Quarterly revenue - Rate of surprise